Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
AstraZeneca
Merck
Moodys
Boehringer Ingelheim

Last Updated: May 20, 2022

VISIONBLUE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Visionblue, and what generic alternatives are available?

Visionblue is a drug marketed by Dorc and is included in one NDA.

The generic ingredient in VISIONBLUE is trypan blue. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the trypan blue profile page.

Summary for VISIONBLUE
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
Raw Ingredient (Bulk) Api Vendors: 34
Formulation / Manufacturing:see details
What excipients (inactive ingredients) are in VISIONBLUE?VISIONBLUE excipients list
DailyMed Link:VISIONBLUE at DailyMed
Drug patent expirations by year for VISIONBLUE
Pharmacology for VISIONBLUE
Drug ClassDiagnostic Dye
Mechanism of Action Dyes

US Patents and Regulatory Information for VISIONBLUE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dorc VISIONBLUE trypan blue SOLUTION;OPHTHALMIC 021670-001 Dec 16, 2004 RX Yes Yes See Plans and Pricing See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for VISIONBLUE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Dorc VISIONBLUE trypan blue SOLUTION;OPHTHALMIC 021670-001 Dec 16, 2004 See Plans and Pricing See Plans and Pricing
Dorc VISIONBLUE trypan blue SOLUTION;OPHTHALMIC 021670-001 Dec 16, 2004 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
McKinsey
Baxter
Express Scripts
Moodys
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.